Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Short Interest Update

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) was the recipient of a large decline in short interest during the month of August. As of August 31st, there was short interest totalling 2,757,700 shares, a decline of 11.7% from the August 15th total of 3,121,400 shares. Based on an average daily volume of 1,500 shares, the days-to-cover ratio is currently 1,838.5 days.

Genomma Lab Internacional Stock Performance

Shares of Genomma Lab Internacional stock opened at $1.07 on Wednesday. Genomma Lab Internacional has a 12-month low of $0.79 and a 12-month high of $1.07. The business’s 50 day moving average is $0.98 and its 200-day moving average is $0.94.

About Genomma Lab Internacional

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.